Harkness Eye Institute, Columbia University Irving Medical Center, New York, NY, 10032, USA.
BMC Ophthalmol. 2020 Jan 6;20(1):13. doi: 10.1186/s12886-019-1282-z.
Bilateral Acute Depigmentation of the Iris (BADI) is a condition which was first described in a case series from Turkey by Tugal-Tutkin and Urgancioglu in (Graefes Arch Clin Exp Ophthalmol 244:742-6, 2006). The condition is characterized by bilateral acute depigmentation and discoloration of the iris stroma, pigment dispersion, and deposition of pigment in the angle. In our case we report a patient who developed BADI after receiving pitcher plant extract injections for chronic migraine, while her identical twin sister has normal iris architecture and pigmentation and never received any pitcher plant injections.
Patient is a 41-year-old female with history of pitcher plant extract injections to her face for chronic migraine, who later developed bilateral depigmentation of the iris. She did not have any signs of anterior segment uveitis or iridocyclitis. She has an identical twin sister who maintained normal iris pigmentation during the entire course.
Bilateral Acute depigmentation of the is a recently discovered condition described in the literature in Turkish patients (Tugal-Tutkun and Urgancioglu, Graefes Arch Clin Exp Ophthalmol 244:742-6, 2006; Tugal-Tutkun et al., Ophthalmology 116(8):1552-7, 2009). This condition affects mainly young females and is characterized by acute bilateral stromal depigmentation, without other pathologic ocular findings. These patients usually maintain normal vision and do not develop significant glaucoma from pigment collecting in the anterior chamber angle. This condition can be mistaken for Fuchs' heterochromic iridocyclitis, pigment dispersion syndrome, pseudoexfoliation syndrome, and viral iridocyclitis. This is the first reported case in North America and is important for differentiation from the above pathologies. Our patient had a history of pitcher plant extract injections to the face but it is unclear if this is associated with our patient's development of BADI. As awareness of this condition progresses, a possible etiology may be elucidated.
双侧急性虹膜脱色素症(Bilateral Acute Depigmentation of the Iris,BADI)是一种疾病,最初由土耳其的 Tugal-Tutkin 和 Urgancioglu 在(Graefes Arch Clin Exp Ophthalmol 244:742-6, 2006)的病例系列中描述。该病症的特征是双侧急性虹膜基质脱色素和变色、色素弥散以及前房角色素沉着。在我们的病例中,我们报告了一位患者,她在接受猪笼草提取物注射治疗慢性偏头痛后出现 BADI,而她的同卵双胞胎妹妹的虹膜结构和色素正常,从未接受过任何猪笼草提取物注射。
患者是一位 41 岁女性,因慢性偏头痛接受了猪笼草提取物面部注射,随后出现双侧虹膜脱色素。她没有任何前节葡萄膜炎或虹膜炎的迹象。她有一个同卵双胞胎妹妹,在整个过程中虹膜色素正常。
双侧急性虹膜脱色素症是一种最近在土耳其患者文献中描述的疾病(Tugal-Tutkun 和 Urgancioglu,Graefes Arch Clin Exp Ophthalmol 244:742-6, 2006;Tugal-Tutkun 等人,Ophthalmology 116(8):1552-7, 2009)。这种疾病主要影响年轻女性,其特征是急性双侧基质脱色素,没有其他眼部病理发现。这些患者通常保持正常视力,并且不会因前房角色素积聚而导致明显青光眼。这种情况可能被误诊为 Fuchs 异色性虹膜炎、色素播散综合征、假性剥脱综合征和病毒性虹膜炎。这是北美首例报告病例,对于与上述病变的鉴别很重要。我们的患者有猪笼草提取物面部注射史,但尚不清楚这是否与她的 BADI 发展有关。随着对这种情况的认识不断提高,可能会阐明其可能的病因。